Premium
TargeTron Technology Applicable in Solventogenic Clostridia: Revisiting 12 Years’ Advances
Author(s) -
Wen Zhiqiang,
Lu Minrui,
LedesmaAmaro Rodrigo,
Li Qi,
Jin Mingjie,
Yang Sheng
Publication year - 2020
Publication title -
biotechnology journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.144
H-Index - 84
eISSN - 1860-7314
pISSN - 1860-6768
DOI - 10.1002/biot.201900284
Subject(s) - clostridia , gene , clostridium , homologous recombination , biology , computational biology , plasmid , crispr , genetics , microbiology and biotechnology , bacteria
Clostridium has great potential in industrial application and medical research. But low DNA repair capacity and plasmids transformation efficiency severely delay development and application of genetic tools based on homologous recombination (HR). TargeTron is a gene editing technique dependent on the mobility of group II introns, rather than homologous recombination, which makes it very suitable for gene disruption of Clostridium . The application of TargeTron technology in solventogenic Clostridium is academically reported in 2007 and this tool has been introduced in various clostridia as it is easy to operate, time saving, and reliable. TargeTron has made great progress in solventogenic Clostridium in the aspects of acetone–butanol–ethanol (ABE) fermentation pathway modification, important functional genes identification, and xylose metabolic pathway analysis and reconstruction. In the review, 12 years’ advances of TargeTron technology applicable in solventogenic Clostridium , including its principle, technical characteristics, application, and efforts to expand its capabilities, or to avoid potential drawbacks, are revisisted. Some other technologies as putative competitors or collaborators are also discussed. It is believed that TargeTron combined with CRISPR/Cas‐assisted gene/base editing and gene‐expression regulation system will make a better future for clostridial genetic modification.